
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
National report - Many dermatologists, especially pediatric dermatologists, have embraced 2-octyl cyanoacrylate tissue adhesive (Dermabond, Ethicon) as an alternative to using standard sutures and staples in selected patients. Dermabond has evolved, as a result of early complaints about dripping and smearing, to offer a new, higher-viscosity formulation. But it's unclear how effective the tissue adhesive is when skin tension exists.